NTRK1 gene rearrangements in NSCLC were first described in 2013 among a subset of patients with NSCLC with adenocarcinoma histology and no detectable EGFR, KRAS, ALK or ROS1 alterations (3/91; 3.3%) [80]. Here, NTRK1 is linked to non-small cell lung carcinoma.